As the opioid crisis continues to impact communities across the world, a physician-scientist at USA Health has been named the principal investigator of an international phase II clinical trial to evaluate the safety of a drug for babies born with neonatal opioid withdrawal syndrome.
Richard M. Whitehurst, Jr., M.D.NeonatologistProfessor of PediatricsSpecialty: Pediatrics
- American Board of Pediatrics (Neonatal-Perinatal Medicine)
- Medical School: University of South Alabama College of Medicine | Mobile, AL
- Residency: University of South Alabama College of Medicine | Mobile, AL
- Fellowship: Jackson Memorial Hospital | Miami, FL